Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers

计划入组 213 人 · 首次发布于 2016 年 7 月 20 日

PRION-1: Quinacrine for Human Prion Disease

计划入组 160 人 · 首次发布于 2005 年 3 月 4 日

The Role of the Coagulation Pathway at the Synapse in Prion Diseases

计划入组 50 人 · 首次发布于 2015 年 6 月 24 日

CART-ASCT-CART2 cells Therapy(Institute Of Hematology & Blood Diseases Hospital)

UCL-2200

VSV-SUDV

Jiangsu Institute of Parasitic Diseases

China

NATIONAL INSTITUTE OF CARDIOVASCULAR DISEASES

Bangladesh

NATIONAL INSTITUTE OF INFECTIOUS DISEASES

Japan

Alzheimer's Disease Transmission Linked to Discontinued Growth Hormone Treatment

Broad Institute Selects Argonaut to Manufacture siRNA Therapeutic for Pioneering Prion Disease Trial

Sangamo Therapeutics to Showcase Breakthrough Prion Disease Treatment at ASGCT Annual Meeting